CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

January 11, 2017 · Phase 2 readout

ALKS Phase 2 readout: a negative outcome, -6.7%

On January 11, 2017, Alkermes plc reached its Phase 2 readout. The result was a negative outcome, and the stock moved -6.7% in the window around the event. It had already run +8.2% in the 30 days into the catalyst — the kind of pre-event run-up that often precedes binary readouts.

The move

$54.44
1d before
$50.82
Event day
$50.87
1d after
$51.62
5d after

Pre-catalyst setup

+8.2%
30-day run-up
3733%
30-day volatility
1.1×
volume spike